SGHT Q3 2025 Earnings — Sight Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SGHTSight Sciences, Inc.

$224M

Q3 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$20M-1.2% YoY

Gross Profit

$17M86.4% margin

Operating Income

-$8M-39.7% margin

Net Income

-$8M-41.0% margin

EPS (Diluted)

$-0.16

QoQ Revenue Growth

+1.7%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$116M

Total Liabilities

$52M

Stockholders' Equity

$64M

Cash & Equivalents

$92M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$20M	-1.2%
Gross Profit	$17M	$17M	+1.7%
Operating Income	-$8M	-$11M	+29.6%
Net Income	-$8M	-$11M	+26.2%

Revenue Segments

Surgical Glaucoma

$20M99%

Dry Eye

$188,0001%